205 related articles for article (PubMed ID: 22865631)
1. Gallic acid downregulates matrix metalloproteinase-2 (MMP-2) and MMP-9 in human leukemia cells with expressed Bcr/Abl.
Chen YJ; Chang LS
Mol Nutr Food Res; 2012 Sep; 56(9):1398-412. PubMed ID: 22865631
[TBL] [Abstract][Full Text] [Related]
2. Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway.
Liu WH; Chang LS
J Cell Physiol; 2010 Sep; 224(3):775-85. PubMed ID: 20432471
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin induces NFκB/p65 down-regulation and JNK1/c-Jun/ATF-2 activation, leading to matrix metalloproteinase-9 (MMP-9) but not MMP-2 down-regulation in human leukemia cells.
Chen YJ; Chang LS
Biochem Pharmacol; 2014 Dec; 92(4):530-43. PubMed ID: 25316568
[TBL] [Abstract][Full Text] [Related]
4. Suppression of ERK signaling evokes autocrine Fas-mediated death in arachidonic acid-treated human chronic myeloid leukemia K562 cells.
Chen KC; Liu WH; Chang LS
J Cell Physiol; 2010 Mar; 222(3):625-34. PubMed ID: 19927299
[TBL] [Abstract][Full Text] [Related]
5. JNK1/c-Jun and p38 alpha MAPK/ATF-2 pathways are responsible for upregulation of Fas/FasL in human chronic myeloid leukemia K562 cells upon exposure to Taiwan cobra phospholipase A2.
Chen KC; Chiou YL; Chang LS
J Cell Biochem; 2009 Oct; 108(3):612-20. PubMed ID: 19670268
[TBL] [Abstract][Full Text] [Related]
6. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
[TBL] [Abstract][Full Text] [Related]
7. Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Chen YJ; Lin KN; Jhang LM; Huang CH; Lee YC; Chang LS
Chem Biol Interact; 2016 May; 252():131-40. PubMed ID: 27087131
[TBL] [Abstract][Full Text] [Related]
8. Adaphostin promotes caffeine-evoked autocrine Fas-mediated death pathway activation in Bcr/Abl-positive leukaemia cells.
Liu WH; Chang LS
Biochem J; 2011 Nov; 439(3):453-67. PubMed ID: 21745187
[TBL] [Abstract][Full Text] [Related]
9. Arachidonic acid induces Fas and FasL upregulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway.
Liu WH; Chang LS
Toxicol Lett; 2009 Dec; 191(2-3):140-8. PubMed ID: 19720122
[TBL] [Abstract][Full Text] [Related]
10. IL-1beta induces MMP-9 expression via a Ca2+-dependent CaMKII/JNK/c-JUN cascade in rat brain astrocytes.
Wu CY; Hsieh HL; Sun CC; Yang CM
Glia; 2009 Dec; 57(16):1775-89. PubMed ID: 19455716
[TBL] [Abstract][Full Text] [Related]
11. Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells.
Hong IK; Kim YM; Jeoung DI; Kim KC; Lee H
Exp Mol Med; 2005 Jun; 37(3):230-9. PubMed ID: 16000878
[TBL] [Abstract][Full Text] [Related]
12. Hydroquinone-induced miR-122 down-regulation elicits ADAM17 up-regulation, leading to increased soluble TNF-α production in human leukemia cells with expressed Bcr/Abl.
Chen YJ; Chang LS
Biochem Pharmacol; 2013 Sep; 86(5):620-31. PubMed ID: 23791922
[TBL] [Abstract][Full Text] [Related]
13. EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways.
Kajanne R; Miettinen P; Mehlem A; Leivonen SK; Birrer M; Foschi M; Kähäri VM; Leppä S
J Cell Physiol; 2007 Aug; 212(2):489-97. PubMed ID: 17348021
[TBL] [Abstract][Full Text] [Related]
14. Amsacrine suppresses matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in human leukemia cells.
Liu WH; Chen YJ; Chien JH; Chang LS
J Cell Physiol; 2014 May; 229(5):588-98. PubMed ID: 24122234
[TBL] [Abstract][Full Text] [Related]
15. Anti-leukemic effects of gallic acid on human leukemia K562 cells: downregulation of COX-2, inhibition of BCR/ABL kinase and NF-κB inactivation.
Chandramohan Reddy T; Bharat Reddy D; Aparna A; Arunasree KM; Gupta G; Achari C; Reddy GV; Lakshmipathi V; Subramanyam A; Reddanna P
Toxicol In Vitro; 2012 Apr; 26(3):396-405. PubMed ID: 22245431
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cells.
Yu C; Rahmani M; Almenara J; Subler M; Krystal G; Conrad D; Varticovski L; Dent P; Grant S
Cancer Res; 2003 May; 63(9):2118-26. PubMed ID: 12727828
[TBL] [Abstract][Full Text] [Related]
18. TNF-alpha induces matrix metalloproteinase-9 expression in A549 cells: role of TNFR1/TRAF2/PKCalpha-dependent signaling pathways.
Lee IT; Lin CC; Wu YC; Yang CM
J Cell Physiol; 2010 Aug; 224(2):454-64. PubMed ID: 20333651
[TBL] [Abstract][Full Text] [Related]
19. CIL-102 induces matrix metalloproteinase-2 (MMP-2)/MMP-9 down-regulation via simultaneous suppression of genetic transcription and mRNA stability.
Liu WH; Chen YL; Chang LS
Int J Biochem Cell Biol; 2012 Dec; 44(12):2212-22. PubMed ID: 22964005
[TBL] [Abstract][Full Text] [Related]
20. AP-1 inhibits expression of MMP-2/9 and its effects on rat smooth muscle cells.
Zhang HW; Wang X; Zong ZH; Huo X; Zhang Q
J Surg Res; 2009 Nov; 157(1):e31-7. PubMed ID: 19524937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
